A
$ Value
$0
Shares
100,000
Price
$0
Filed
Nov 26
Insider
Name
Kieffer Tara Lynn
Title
Chief Product Strategy Officer
CIK
0001834835
Roles
Officer
Transaction Details
Transaction Date
2025-11-25
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
100,000
Footnotes
Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 25, 2025).
Filing Info
Kieffer Tara Lynn's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-12 | ENTA | A | $0 |
| 2026-02-12 | ENTA | A | $0 |
| 2026-02-12 | ENTA | F | $46K |
| 2025-12-05 | ENTA | ▼ | $30K |
| 2025-12-01 | ENTA | F | $11K |
| 2025-11-25 | ENTA | A | $0 |
Other Insiders at ENTA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER BRUCE L A | — | — | 2026-03-11 |
| FOLETTA MARK G | — | — | 2026-03-11 |
| Russell Lesley | — | — | 2026-03-11 |
| Peterson Kristine | — | — | 2026-03-11 |
|
Luly Jay R.
President and CEO
|
— | — | 2026-02-12 |
|
Or Yat Sun
Chief Scientific Officer
|
— | — | 2026-02-12 |
| Vance Terry | — | — | 2026-03-11 |
| Hata Yujiro S | — | — | 2026-03-11 |
|
Kowalsky Matthew Paul
Chief Legal Officer
|
— | — | 2026-02-12 |
|
Kieffer Tara Lynn
Chief Product Strategy Officer
|
— | — | 2026-02-12 |
|
Luu Brendan
Chief Business Officer
|
— | — | 2026-02-12 |
|
Rottinghaus Scott T.
Chief Medical Officer
|
— | — | 2026-02-12 |